ENDRA Life Sciences Inc.
NDRA | NASDAQ
$6.10
-$0.21 (-3.33%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 39.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -39.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | n/a | -2.17M | -1.62M | -1.37M | -1.3M | -1.47M | -4.3M | -1.51M | -2.23M | -2.78M | -1.46M | -3.13M | -2.99M | -2.94M | -3.31M | -3.42M | -3.57M | -2.86M | -3.07M | -2.65M | -3.2M | -2.58M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 159.94K | -1.31M | -3.17M | -1.6M | -1.23M | -1.04M | -4.15M | -2.35M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M | -2.94M | -3.29M | -3.44M | -3.59M | -2.86M | -3.1M | -2.66M | -3.2M | -2.27M |
Net Income | 159.94K | -1.31M | -3.17M | -1.6M | -1.23M | -1.04M | -4.15M | -2.35M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M | -2.94M | -3.29M | -3.44M | -3.59M | -2.86M | -3.1M | -2.66M | -3.2M | -2.27M |
Selling & General & Admin | 1.25M | 1.4M | 1.11M | 938.59K | 920.03K | 940.6K | 3.66M | 714.57K | 1.51M | 1.74M | 878.43K | 1.5M | 1.59M | 1.55M | 1.65M | 1.59M | 1.72M | 1.64M | 1.65M | 1.48M | 1.46M | 1.43M |
Research & Development | 233.67K | 776.41K | 508.14K | 432.11K | 381.06K | 528.69K | 637.96K | 794.44K | 716.37K | 1.04M | 579.35K | 1.63M | 1.4M | 1.39M | 1.66M | 1.83M | 1.85M | 1.21M | 1.42M | 1.17M | 1.74M | 1.14M |
Other Expenses | n/a | -39.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.48M | 2.13M | 1.62M | 1.37M | 1.3M | 1.47M | 4.3M | 1.51M | 2.23M | 2.78M | 1.46M | 3.13M | 2.99M | 2.94M | 3.31M | 3.42M | 3.57M | 2.86M | 3.07M | 2.65M | 3.2M | 2.58M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.32M | n/a | n/a | n/a | n/a | n/a | 3.42K | n/a | 23.01K | 19.37K | 2.86T | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 5.81K | 4.28K | 6.36K | 45.29K | 68.83K | 68.99K | 86.27K | 83.16K | 162.95K | 238.66K | 147.83K | 243.33K | 247.77K | 181.62K | 326.77K | 420.44K | 342.04K | 339.9K | 382.11K | 275.57K | 256.76K | 160.94K |
Cost & Expenses | n/a | 2.17M | 1.62M | 1.37M | 1.3M | 1.47M | 4.3M | 1.51M | 2.23M | 2.78M | 1.46M | 3.13M | 2.99M | 2.94M | 3.31M | 3.42M | 3.57M | 2.86M | 3.07M | 2.65M | 3.2M | 2.58M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.32M | 1.2M | 787.02K | 761.22K | 717.11K | 557.58K | 536.91K | 1.12M | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M | 1.93M | 1.93M | 1.93M | 1.93M | 2.15M | 2.1M | 2.1M | 2.08M | 1.89M |
Shares Outstanding (Diluted) | 2.48M | 1.2M | 787.02K | 761.22K | 717.11K | 557.58K | 536.91K | 1.12M | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M | 1.93M | 1.93M | 1.93M | 1.93M | 2.15M | 2.1M | 2.1M | 2.08M | 1.89M |
EPS (Basic) | 0.12 | -1.09 | -3.26 | -2.10 | -1.71 | -1.86 | -7.73 | -2.10 | -1.31 | -1.63 | -0.85 | -1.82 | -1.50 | -1.53 | -1.69 | -1.79 | -1.87 | -1.33M | -1.48 | -1.27 | -1.54 | -1.20 |
EPS (Diluted) | 0.06 | -1.09 | -3.26 | -2.10 | -1.71 | -1.86 | -7.73 | -2.10 | -1.31 | -1.63 | -0.85 | -1.82 | -1.50 | -1.53 | -1.69 | -1.79 | -1.87 | -1.33M | -1.48 | -1.27 | -1.54 | -1.20 |
EBITDA | n/a | -1.27M | -3.13M | -1.56M | -1.19M | -990.75K | -4.1M | 5.02M | -2.18M | -2.72M | -1.4M | -3.03M | -2.48M | -2.87M | -3.22M | -3.36M | -3.52M | 2.86T | -3.05M | -2.6M | -3.14M | -2.53M |
EBIT | n/a | -1.31M | -3.17M | -1.6M | -1.23M | -1.04M | -4.15M | 4.97M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M | -2.94M | -3.29M | -3.42M | -3.57M | 2.86T | -3.1M | -2.66M | -3.2M | -2.58M |
Depreciation & Amortization | n/a | 39.72K | 39.53K | 39.39K | 32.79K | 45.58K | 46.36K | 54.01K | 50.12K | 55.68K | 61.25K | 70.45K | 72.71K | 71.04K | 67.77K | 58.59K | 55.68K | 52.22K | 53.67K | 61.51K | 60.37K | 48.87K |
Add to Watchlist
Select watchlists to add or remove NDRA